BIOMAT Database Logo BIOMAT Database Logo

Mycoplasma pneumonia: failure of erythromycin therapy. 1980

M J Ford, and W A Telfer Brunton, and J Millar, and C Stewart, and J A Critchley

Two cases of mycoplasma pneumonia are described which failed to respond to prolonged treatment with erythromycin. The substitution of oxytetracycline therapy resulted in rapid clinical and radiological resolution.

UI MeSH Term Description Entries
D008297 Male Males
D010118 Oxytetracycline A TETRACYCLINE analog isolated from the actinomycete STREPTOMYCES RIMOSUS and used in a wide variety of clinical conditions. Hydroxytetracycline,Bisolvomycin,Geomycin,Oxyterracin,Oxyterracine,Oxytetracid,Oxytetracycline Anhydrous,Oxytetracycline Calcium,Oxytetracycline Dihydrate,Oxytetracycline Hydrochloride,Oxytetracycline Monohydrochloride,Oxytetracycline Sulfate (2:1),Oxytetracycline, (4a beta,5 beta,5a beta,12a beta)-Isomer,Oxytetracycline, (5 beta)-Isomer,Oxytetracycline, Anhydrous,Oxytetracycline, Calcium (1:1) Salt,Oxytetracycline, Disodium Salt, Dihydrate,Oxytetracycline, Sodium Salt,Terramycin
D011019 Pneumonia, Mycoplasma Interstitial pneumonia caused by extensive infection of the lungs (LUNG) and BRONCHI, particularly the lower lobes of the lungs, by MYCOPLASMA PNEUMONIAE in humans. In SHEEP, it is caused by MYCOPLASMA OVIPNEUMONIAE. In CATTLE, it may be caused by MYCOPLASMA DISPAR. Mycoplasma Pneumonia,Pneumonia, Primary Atypical,Mycoplasma dispar Infection,Mycoplasma ovipneumoniae Infection,Mycoplasma pneumoniae Infection,Atypical Pneumonia, Primary,Atypical Pneumonias, Primary,Mycoplasma Pneumonias,Mycoplasma dispar Infections,Mycoplasma ovipneumoniae Infections,Mycoplasma pneumoniae Infections,Pneumonias, Mycoplasma,Pneumonias, Primary Atypical,Primary Atypical Pneumonia,Primary Atypical Pneumonias
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M J Ford, and W A Telfer Brunton, and J Millar, and C Stewart, and J A Critchley
Comparison of josamycin and erythromycin in the therapy of Mycoplasma pneumoniae pneumonia.
December 1976, Antimicrobial agents and chemotherapy,
M J Ford, and W A Telfer Brunton, and J Millar, and C Stewart, and J A Critchley
Therapeutic effect of erythromycin on Mycoplasma pneumoniae pneumonia.
January 1965, Antimicrobial agents and chemotherapy,
M J Ford, and W A Telfer Brunton, and J Millar, and C Stewart, and J A Critchley
Mycoplasma pneumoniae pneumonia and clindamycin therapy. Failure to demonstrate efficacy.
May 1974, JAMA,
M J Ford, and W A Telfer Brunton, and J Millar, and C Stewart, and J A Critchley
Mycoplasma infection and erythromycin therapy in childhood.
December 1977, Scottish medical journal,
M J Ford, and W A Telfer Brunton, and J Millar, and C Stewart, and J A Critchley
Failure of erythromycin/rifampicin treatment of legionella pneumonia.
May 1985, The Journal of infection,
M J Ford, and W A Telfer Brunton, and J Millar, and C Stewart, and J A Critchley
Application value of erythromycin combined with azithromycin sequential therapy in the treatment of mycoplasma pneumonia in children.
April 2022, Minerva pediatrics,
M J Ford, and W A Telfer Brunton, and J Millar, and C Stewart, and J A Critchley
Failure of erythromycin in treatment of Legionella micdadei pneumonia.
February 1984, The American journal of medicine,
M J Ford, and W A Telfer Brunton, and J Millar, and C Stewart, and J A Critchley
Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin therapy.
May 1967, The New England journal of medicine,
M J Ford, and W A Telfer Brunton, and J Millar, and C Stewart, and J A Critchley
[Mycoplasma pneumonia complicated by acute renal failure].
June 2001, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society,
M J Ford, and W A Telfer Brunton, and J Millar, and C Stewart, and J A Critchley
[Acute respiratory failure due to Mycoplasma pneumonia].
November 2013, Revue des maladies respiratoires,
Copied contents to your clipboard!